Chapter 69
Cardiovascular Manifestations of Pediatric Rheumatic Diseases
Bryce A. Binstadt MD, PhD,
Bryce A. Binstadt MD, PhD
Division of Rheumatology, Department of Pediatrics and Center for Immunology, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorBryce A. Binstadt MD, PhD,
Bryce A. Binstadt MD, PhD
Division of Rheumatology, Department of Pediatrics and Center for Immunology, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorBook Editor(s):James H. Moller MD,
Julien I. E. Hoffman MD, FRCP,
James H. Moller MD
University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorJulien I. E. Hoffman MD, FRCP
University of California San Francisco, San Francisco, CA, USA
Search for more papers by this authorFirst published: 13 January 2012
Summary
Essentially all pediatric rheumatic diseases can affect the cardiovascular system. This chapter discusses the most common cardiovascular manifestations of these diverse diseases. The link between chronic inflammatory disease and long-term risk of coronary artery disease is highlighted, with emphasis on controlling the inflammatory state to improve long-term cardiac outcomes. The cardiovascular side effects of anti-rheumatic medications are discussed, as are rheumatic conditions induced by cardiovascular drugs.
References
- Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005; 52: 402–11.
- Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408–15.
- Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390–2.
- Goldenberg J, Ferraz MB, Pessoa AP, et al. Symptomatic cardiac involvement in juvenile rheumatoid arthritis. Int J Cardiol 1992; 34: 57–62.
- Svantesson H, Bjorkhem G, Elborgh R. Cardiac involvement in juvenile rheumatoid arthritis. A follow-up study. Acta Paediatr Scand 1983; 72: 345–50.
- Brewer E Jr. Juvenile rheumatoid arthritis – cardiac involvement. Arthritis Rheum 1977; 20: 231–6.
- Stingl C, Moller JH, Binstadt BA. Cardiac operations for North American children with rheumatic diseases: 1985–2005. Pediatr Cardiol 2010; 31: 66–73.
- Yancey CL, Doughty RA, Cohlan BA, et al. Pericarditis and cardiac tamponade in juvenile rheumatoid arthritis. Pediatrics 1981; 68: 369–73.
- Soylemezoglu O, Besbas N, Ozkutlu S, et al. Dilated cardiomyopathy in juvenile chronic arthritis. Scand J Rheumatol 1994; 23: 159–61.
- Kramer PH, Imboden JB Jr, Waldman FM, et al. Severe aortic insufficiency in juvenile chronic arthritis. Am J Med 1983; 74: 1088–91.
- Heyd J, Glaser J. Early occurrence of aortic valve regurgitation in a youth with systemic-onset juvenile rheumatoid arthritis. Am J Med 1990; 89: 123–4.
- Binstadt BA, Levine JC, Nigrovic PA, et al. Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. Pediatrics 2005; 116: e89–93.
- Komatsu H, Tateno A. Failure to distinguish systemic-onset juvenile idiopathic arthritis from incomplete Kawasaki disease in an infant. J Paediatr Child Health 2005; 43: 707–9.
- Ravelli A, Magni-Manzoni S, Pistorio A, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005; 146: 598–604.
- Delgado EA, Petty RE, Malleson PN, et al. Aortic valve insufficiency and coronary artery narrowing in a child with polyarticular juvenile rheumatoid arthritis. J Rheumatol 1988; 15: 144–7.
- Ozer S, Alehan D, Ozme S, et al. Mitral and aortic insufficiency in polyarticular juvenile rheumatoid arthritis. Pediatr Cardiol 1994; 15: 151–3.
- Boris JR, Hollister JR, Tyson RW, et al. Severe aortic regurgitation with mechanical prosthetic valve replacement in pauciarticular juvenile rheumatoid arthritis. J Rheumatol 1998; 25: 1211–4.
- Bharti BB, Kumar S, Kapoor A, et al. Assessment of left ventricular systolic and diastolic function in juvenile rheumatoid arthritis. J Postgrad Med 2004; 50: 262–5; discussion 266–7.
- Kavey RE, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2006; 114: 2710–38.
- Jimenez-Balderas FJ, Garcia-Rubi D, Perez-Hinojosa S, et al. Two-dimensional echo Doppler findings in juvenile and adult onset ankylosing spondylitis with long-term disease. Angiology 2001; 52: 543–8.
- Huppertz H, Voigt I, Muller-Scholden J, et al. Cardiac manifestations in patients with HLA B27-associated juvenile arthritis. Pediatr Cardiol 2000; 21: 141–7.
- Stamato T, Laxer RM, de Freitas C, et al. Prevalence of cardiac manifestations of juvenile ankylosing spondylitis. Am J Cardiol 1995; 75: 744–6.
- Dik VK, Peters MJ, Dijkmans PA, et al. The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis. Scand J Rheumatol 2010; 39: 38–41.
- Gladman DD, Ang M, Su L, et al. Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 2009; 68: 1131–5.
- Kimball AB, Guerin A, Latremouille-Viau D, et al. Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis. Am J Med 2010; 123: 350–7.
- Hiraki LT, Benseler SM, Tyrrell PN, et al. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 2008; 152: 550–6.
- Yeh TT, Yang YH, Lin YT, et al. Cardiopulmonary involvement in pediatric systemic lupus erythematosus: a twenty-year retrospective analysis. J Microbiol Immunol Infect 2007; 40: 525–31.
- Nigrovic PA, Fuhlbrigge RC, Sundel RP. Raynaud's phenomenon in children: a retrospective review of 123 patients. Pediatrics 2003; 111: 715–21.
- Al-Abbad AJ, Cabral DA, Sanatani S, et al. Echocardiography and pulmonary function testing in childhood onset systemic lupus erythematosus. Lupus 2001; 10: 32–7.
- Oshiro AC, Derbes SJ, Stopa AR, et al. Anti-Ro/SS-A and anti-La/SS-B antibodies associated with cardiac involvement in childhood systemic lupus erythematosus. Ann Rheum Dis 1997; 56: 272–4.
- Gazarian M, Feldman BM, Benson LN, et al. Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus. J Pediatr 1998; 132: 109–16.
- Gunal N, Kara N, Akkok N, et al. Cardiac abnormalities in children with systemic lupus erythematosus. Turk J Pediatr 2003; 45: 301–5.
- Stichweh D, Arce E, Pascual V. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 2004; 16: 577–87.
-
Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2331–7.
10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I CAS PubMed Web of Science® Google Scholar
- Korkmaz C, Cansu DU, Kasifoglu T. Myocardial infarction in young patients (< or = 35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature. Lupus 2007; 16: 289–97.
- Doria A, Iaccarino L, Sarzi-Puttini P, et al. Cardiac involvement in systemic lupus erythematosus. Lupus 2005; 14: 683–6.
- Hashkes PJ, Wexler LF, Passo MH. Coronary artery disease in systemic lupus erythematosus: risk factors, assessment, and prevention. J Clin Rheumatol 1997; 3: 203–10.
- Falaschi F, Ravelli A, Martignoni A, et al. Nephrotic-range pro teinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2000; 43: 1405–9.
- Marini R, Costallat LT. Young age at onset, renal involvement, and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus. Rev Rhum Engl Ed 1999; 66: 303–309.
- Ilowite NT, Samuel P, Ginzler E, et al. Dyslipoproteinemia in pediatric systemic lupus erythematosus. Arthritis Rheum 1988; 31: 859–63.
- Eronen M, Siren MK, Ekblad H, et al. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000; 106: 86–91.
- Brucato A, Cimaz R, Caporali R, et al. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol 2011; 40: 27–41.
- Buyon JP, Clancy RM, Friedman DM. Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside. Nat Clin Pract Rheumatol 2009; 5: 139–48.
- Faurschou M, Mellemkjaer L, Sorensen IJ, et al. Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis. Arthritis Rheum 2009; 60: 1187–92.
- Greidinger EL, Lemes V, Hellmann DB. Cardiac valve disease in Wegener's granulomatosis. J Rheumatol 1996; 23: 1485–7.
- Rottem M, Fauci AS, Hallahan CW, et al. Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 1993; 122: 26–31.
- Neumann T, Manger B, Schmid M, et al. Cardiac involvement in Churg–Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore) 2009; 88: 236–43.
- Zwerina J, Eger G, Englbrecht M, et al. Churg–Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients. Semin Arthritis Rheum 2009; 39: 108–15.
- Gunal N, Kara N, Cakar N, et al. Cardiac involvement in childhood polyarteritis nodosa. Int J Cardiol 1997; 60: 257–62.
- Ravelli A, Pedroni E, Perrone S, et al. Aortic valve regurgitation as the presenting sign of Takayasu arteritis. Eur J Pediatr 1999; 158: 281–3.
- Civilibal M, Sever L, Numan F, et al. Dissection of the abdominal aorta in a child with Takayasu's arteritis. Acta Radiol 2008 49: 101–4.
- Basso C, Baracca E, Zonzin P, et al. Sudden cardiac arrest in a teenager as first manifestation of Takayasu's disease. Int J Cardiol 1994; 43: 87–9.
- Su JW, Low AH, Tay KH, et al. Recurrent aortic aneurysms following thoracic aortic stent-graft repair in a patient with Cogan syndrome. J Endovasc Ther 2006; 13: 779–82.
- Ozen S, Bilginer Y, Besbas N, et al. Behçet disease: treatment of vascular involvement in children. Eur J Pediatr 2010; 169: 427–30.
- Vivante A, Bujanover Y, Jacobson J, et al. Intracardiac thrombus and pulmonary aneurysms in an adolescent with Behçet disease. Rheumatol Int 2009; 29: 575–7.
- Zhuang J, Wang S, Zhang Z, et al. Acute myocardial infarction and ascending aortic aneurysm in a child with Behçet disease. Turk J Pediatr 2008; 50: 81–5.
- Mirone L, Altomonte L, Ferlisi EM, et al. Behçet's disease and cardiac arrhythmia. Clin Rheumatol 1997; 16: 99–100.
- Carlson JA, Chen KR. Cutaneous pseudovasculitis. Am J Dermatopathol 2007; 29: 44–55.
- Kim S, El-Hallak M, Dedeoglu F, et al. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment. Arthritis Rheum 2009; 60: 1825–30.
- Pereira RM, Lerner S, Maeda WT, et al. Pericardial tamponade in juvenile dermatomyositis. Clin Cardiol 1992; 15: 301–3.
- Karaca NE, Aksu G, Yeniay BS, et al. Juvenile dermatomyositis with a rare and remarkable complication: sinus bradycardia. Rheumatol Int 2006; 27: 179–82.
- Cutolo M, Sulli A, Secchi ME, et al. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology (Oxford) 2006; 45(Suppl 4): iv43–6.
- Quartier P, Bonnet D, Fournet JC, et al. Severe cardiac involvement in children with systemic sclerosis and myositis. J Rheumatol 2002; 29: 1767–73.
- Martini G, Vittadello F, Kasapcopur O, et al. Factors affecting survival in juvenile systemic sclerosis. Rheumatology (Oxford) 2009; 48: 119–22.
- Scalapino K, Arkachaisri T, Lucas M, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol 2006; 33: 1004–13.
- Foeldvari I, Zhavania M, Birdi N, et al. Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multinational survey. Rheumatology (Oxford) 2000; 39: 556–9.
- Wozniak J, Dabrowski R, Luczak D, et al. Evaluation of heart rhythm variability and arrhythmia in children with systemic and localized scleroderma. J Rheumatol 2009; 36: 191–6.
- Mouthon L, Bérezné A, Bussone G, et al. Scleroderma renal crisis: a rare but severe complication of systemic sclerosis. Clin Rev Allergy Immunol. 2011; 40: 84–91
- Quillinan NP, Denton CP. Disease-modifying treatment in systemic sclerosis: current status. Curr Opin Rheumatol 2009; 21: 636–41.
- Burton DA, Kapur S, Shapiro SR, et al. Fulminant cardiac sarcoidosis in childhood. Am J Cardiol 1986; 58: 177–8.
- Duke C, Rosenthal E. Sudden death caused by cardiac sarcoidosis in childhood. J Cardiovasc Electrophysiol 2002; 13: 939–42.
- Silver E, Pass RH, Kaufman S, et al. Complete heart block due to Lyme carditis in two pediatric patients and a review of the literature. Congenit Heart Dis 2007; 2: 338–41.
- Woolf PK, Lorsung EM, Edwards KS, et al. Electrocardiographic findings in children with Lyme disease. Pediatr Emerg Care 1991; 7: 334–6.
- Mravljak M, Velnar T, Bricelj V, et al. Electrocardiographic findings in children with erythema migrans. Wien Klin Wochenschr 2006; 118: 691–5.
- Dedeoglu F. Drug-induced autoimmunity. Curr Opin Rheumatol 2009; 21: 547–51.
- Mor A, Pillinger MH, Wortmann RL, et al. Drug-induced arthritic and connective tissue disorders. Semin Arthritis Rheum 2008; 38: 249–64.
- Curtis JR, Kramer JM, Martin C, et al. Heart failure among -younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists. Rheumatology (Oxford) 2007; 46: 1688–93.
- Saint Marcoux B, De Bandt M. Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine 2006; 73: 710–3.
- Yokota S, Imagawa T, Mori M, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 2008; 371: 998–1006.
- Storage SS, Agrawal H, Furst DE. Description of the efficacy and safety of three new biologics in the treatment of rheumatoid arthritis. Korean J Intern Med 2010; 25: 1–17.
